# Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

> **NCT06180720** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 36 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- **DRUG:** Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)

## Key facts

- **NCT ID:** NCT06180720
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-20
- **Primary completion:** 2024-01-04
- **Final completion:** 2024-11-20
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06180720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06180720, "Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06180720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*